Abraxis Oncology
 
Bookmark Send to a Colleague

Medical Affairs

Home > Medical Affairs > Investigator-Sponsored Studies

Investigator-Sponsored Studies

Abraxis™ Oncology has an active investigator-sponsored clinical trials program. Areas of investigation include studies in breast cancer, lung cancer, and melanoma, with exploratory research being conducted in ovarian, prostate, sarcoma, head and neck, bladder and pancreatic cancers. For more information about investigator-sponsored studies, please call 866-224-7511 or e-mail AbraxisMedAffairs@abraxisbio.com.

To learn more about ongoing investigator-sponsored clinical trials and study results, please visit the National Institutes of Health (NIH) clinical trial Web site at www.clinicaltrials.gov.

For more information about ongoing trials at Abraxis, visit our Research and Development section.

Compliance Declaration Investor Relations Site Map Terms of Use Privacy Policy Glossary Comprehensive Bibliography

Abraxis Oncology is a division of Abraxis BioScience, LLC. AO 997/268353 August 2008
All Abraxis BioScience, LLC corporate names (eg, ABRAXIS, ABRAXIS ONCOLOGY, ABRAXIS BIOSCIENCE, and their logos), names of services, and names of products (eg, ABRAXANE® and the ABRAXANE logo) referred to herein are trade names, service marks and/or trademarks that are owned by or licensed to Abraxis BioScience, its divisions, or its affiliates, unless otherwise noted.